EQUASENS (EQS.PA) Stock Fundamental Analysis
Europe - EPA:EQS - FR0012882389 - Common Stock
43.45 EUR
-0.25 (-0.57%)
EQS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 11 industry peers in the Health Care Technology industry. EQS scores excellent on profitability, but there are some minor concerns on its financial health. EQS has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
EQS had positive earnings in the past year.
EQS had a positive operating cash flow in the past year.
EQS had positive earnings in each of the past 5 years.
Each year in the past 5 years EQS had a positive operating cash flow.
1.2 Ratios
EQS's Return On Assets of 9.10% is fine compared to the rest of the industry. EQS outperforms 72.73% of its industry peers.
EQS has a better Return On Equity (15.65%) than 81.82% of its industry peers.
EQS has a Return On Invested Capital of 12.02%. This is amongst the best in the industry. EQS outperforms 81.82% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EQS is significantly above the industry average of 9.32%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.1% | ||
| ROE | 15.65% | ||
| ROIC | 12.02% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
1.3 Margins
EQS has a Profit Margin of 16.72%. This is amongst the best in the industry. EQS outperforms 81.82% of its industry peers.
In the last couple of years the Profit Margin of EQS has remained more or less at the same level.
EQS has a Operating Margin of 20.18%. This is amongst the best in the industry. EQS outperforms 90.91% of its industry peers.
In the last couple of years the Operating Margin of EQS has declined.
Looking at the Gross Margin, with a value of 68.77%, EQS is doing worse than 63.64% of the companies in the same industry.
EQS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.18% | ||
| PM (TTM) | 16.72% | ||
| GM | 68.77% |
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), EQS is creating value.
The number of shares outstanding for EQS remains at a similar level compared to 1 year ago.
EQS has more shares outstanding than it did 5 years ago.
EQS has a better debt/assets ratio than last year.
2.2 Solvency
EQS has an Altman-Z score of 4.18. This indicates that EQS is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.18, EQS is doing good in the industry, outperforming 72.73% of the companies in the same industry.
The Debt to FCF ratio of EQS is 1.29, which is an excellent value as it means it would take EQS, only 1.29 years of fcf income to pay off all of its debts.
EQS has a better Debt to FCF ratio (1.29) than 63.64% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that EQS is not too dependend on debt financing.
The Debt to Equity ratio of EQS (0.12) is better than 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 1.29 | ||
| Altman-Z | 4.18 |
ROIC/WACC1.59
WACC7.58%
2.3 Liquidity
A Current Ratio of 1.21 indicates that EQS should not have too much problems paying its short term obligations.
EQS has a Current ratio (1.21) which is in line with its industry peers.
A Quick Ratio of 1.10 indicates that EQS should not have too much problems paying its short term obligations.
The Quick ratio of EQS (1.10) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.1 |
3. Growth
3.1 Past
EQS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.02%.
The Earnings Per Share has been growing slightly by 5.12% on average over the past years.
EQS shows a decrease in Revenue. In the last year, the revenue decreased by -1.37%.
EQS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.45% yearly.
EPS 1Y (TTM)-23.02%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%-24.02%
Revenue 1Y (TTM)-1.37%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%1.49%
3.2 Future
Based on estimates for the next years, EQS will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.63% on average per year.
The Revenue is expected to grow by 7.74% on average over the next years.
EPS Next Y18.72%
EPS Next 2Y19.01%
EPS Next 3Y18.63%
EPS Next 5YN/A
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 18.18, EQS is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of EQS indicates a somewhat cheap valuation: EQS is cheaper than 63.64% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, EQS is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 15.96, the valuation of EQS can be described as correct.
81.82% of the companies in the same industry are more expensive than EQS, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of EQS to the average of the S&P500 Index (22.73), we can say EQS is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.18 | ||
| Fwd PE | 15.96 |
4.2 Price Multiples
63.64% of the companies in the same industry are more expensive than EQS, based on the Enterprise Value to EBITDA ratio.
EQS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. EQS is cheaper than 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.36 | ||
| EV/EBITDA | 10.73 |
4.3 Compensation for Growth
EQS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of EQS may justify a higher PE ratio.
A more expensive valuation may be justified as EQS's earnings are expected to grow with 18.63% in the coming years.
PEG (NY)0.97
PEG (5Y)3.55
EPS Next 2Y19.01%
EPS Next 3Y18.63%
5. Dividend
5.1 Amount
EQS has a Yearly Dividend Yield of 2.86%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.56, EQS has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.41, EQS has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.86% |
5.2 History
The dividend of EQS is nicely growing with an annual growth rate of 8.00%!
Dividend Growth(5Y)8%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
51.86% of the earnings are spent on dividend by EQS. This is a bit on the high side, but may be sustainable.
The dividend of EQS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP51.86%
EPS Next 2Y19.01%
EPS Next 3Y18.63%
EPA:EQS (9/12/2025, 7:00:00 PM)
43.45
-0.25 (-0.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners10.49%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap659.14M
Analysts80
Price Target50.49 (16.2%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.86% |
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.86%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.13%
PT rev (3m)-13.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-6.75%
EPS NY rev (3m)-6.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.18 | ||
| Fwd PE | 15.96 | ||
| P/S | 3.04 | ||
| P/FCF | 18.36 | ||
| P/OCF | 13.86 | ||
| P/B | 2.85 | ||
| P/tB | 8.08 | ||
| EV/EBITDA | 10.73 |
EPS(TTM)2.39
EY5.5%
EPS(NY)2.72
Fwd EY6.26%
FCF(TTM)2.37
FCFY5.45%
OCF(TTM)3.13
OCFY7.21%
SpS14.29
BVpS15.26
TBVpS5.38
PEG (NY)0.97
PEG (5Y)3.55
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.1% | ||
| ROE | 15.65% | ||
| ROCE | 14.76% | ||
| ROIC | 12.02% | ||
| ROICexc | 14.31% | ||
| ROICexgc | 35.95% | ||
| OM | 20.18% | ||
| PM (TTM) | 16.72% | ||
| GM | 68.77% | ||
| FCFM | 16.57% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.36%
ROICexc(5y)21.38%
ROICexgc(3y)50.59%
ROICexgc(5y)62.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexcg growth 3Y-25.09%
ROICexcg growth 5Y-9.54%
ROICexc growth 3Y-15.77%
ROICexc growth 5Y-10.18%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score5
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 1.29 | ||
| Debt/EBITDA | 0.48 | ||
| Cap/Depr | 79.39% | ||
| Cap/Sales | 5.37% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.41% | ||
| Profit Quality | 99.11% | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z | 4.18 |
F-Score5
WACC7.58%
ROIC/WACC1.59
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-23.02%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%-24.02%
EPS Next Y18.72%
EPS Next 2Y19.01%
EPS Next 3Y18.63%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.37%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%1.49%
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
EBIT growth 1Y-20.84%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year71.53%
EBIT Next 3Y25.63%
EBIT Next 5YN/A
FCF growth 1Y-8.64%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-17.61%
OCF growth 3Y0.02%
OCF growth 5Y3.18%